Payami, B., A. Zarrin, M. Hosseinzadeh, H. Haybar, and S. Khodamoradi. “Amiodarone Can Still Be a Drug of Choice at Emergency Departments for Pre-Excited Atrial Fibrillation Even in the Face of Guidelines Prohibition”. Iranian Journal of Emergency Medicine, vol. 10, no. 1, May 2023, p. e8, doi:10.22037/ijem.v10i1.40732.